IJCS | Volume 33, Nº3, May / June 2020

250 decline in CVD mortality was attributed to changes in risk factor levels in the population, especially reduction in cholesterol levels, blood pressure and smoking. The results of this study are added to others, thus aggregating scientific evidence of correlation between central obesity and changes in the biochemical markers of metabolic risk of older patients, which reinforces the adoption of WC measurements in clinical practice and in epidemiologic studies, due to its ease of application, practicality, accuracy and low cost. However, these results should be carefully analyzed, since this study used a cross-sectional design, which does not allow for causal inferences to be made. Besides, the biochemical data may have been affected by medication taken by the patients. Hence, more robust cohort studies are required to further investigate these parameters, including lifestyle, smoking and blood pressure assessments, as recommended by the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. 10 Conclusion We conclude that there was an association between central obesity and biochemical markers of cardiometabolic risk in the elderly patients who participated in the study. The findings suggest the need for better monitoring of these markers, as well as of VAT accumulation, even considering the use of more accurate measurement techniques, such as computed tomography and magnetic resonance, so that adequate health strategies can be provided in order to reduce the number of hospitalizations and deaths by these causes. Author contributions Conception and design of the research: Oliveira CC, Costa ED. Acquisition of data: Costa ED. Analysis and interpretation of the data: Almeida ACS, Oliveira CC, Deiró AQS. Statistical analysis: Oliveira CC. Obtaining financing: Oliveira CC. Writing of the manuscript: Almeida ACS. Critical revision of the manuscript for intellectual content: Almeida ACS, Oliveira CC, Costa ED, Deiró AQS. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This article is part of the thesis of residence completing work in Clinical Nutrition submitted by Ana Caroline de SouzaAlmeida, fromUniversidade Federal da Bahia. Ethics approval and consent to participate This study was approved by the Ethics Committee of the Hospital Universitário de Aracajú/Universidade Federal de Sergipe under the protocol number 559.936/ 2014. All the procedures in this study were in accordance with the 1975 Helsinki Declaration, updated in 2013. Informed consent was obtained from all participants included in the study. 1. Ding L, Xu Y, Wang L, XuM, Jiang Y, ZhangM, et al. The cardiometabolic risk profile of Chinese adults with diabetes: a nationwide cross-sectional survey. J Diabetes Complications. 2017;31(1):43-52. 2. Maddaloni E, Cavallari I, De Pascalis M, Keenan H, Park K, Manfrini S, et al. Relation of body circumferences to cardiometabolic disease in overweight-obese subjects. Am J Cardiol. 2016;118(6):822-7. 3. Gutiérrez-Repiso C, Soriguer F, Rojo-Martínez G, García-Fuentes E, Valdés S, GodayA, et al. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study. Nutr Metab Cardiovasc Dis. 2014;24(9):947-55. 4. Soar C. Prevalence of cardiovascular risk factors in non-institutionalized elderly. Rev Bras Geriatr Gerontol. 2015;18(2):385-95. 5. Scarsella C, Després JP. Treatment of obesity: the need to target attention on high-risk patients characterized by abdominal obesity. Cad Saude Publica. 2003;19(suppl 1):S7-19. 6. Barroso SG,AbreuVG, Francischetti EA.Aparticipação do tecido adiposo visceral na gênese da hipertensão e doença cardiovascular aterogênica. um conceito emergente. Arq Bras Cardiol. 2002;78(6):618-30. 7. RorizAKC, MelloAL, Guimarães JF, Santos FC, Medeiros JMB, Sampaio LR. Imaging assessment of visceral adipose tissue area and its correlations with metabolic alterations. Arq Bras Cardiol. 2010;95(6):698-704. 8. Hermsdorff HHM, Monteiro. JBR. Gordura visceral, subcutânea ou intramuscular: onde está o problema? Arq Bras Endocrinol Metab. 2004;48(6):803-11. References Oliveira et al. Cardiometabolic risk in elderly Int J Cardiovasc Sci. 2020; 33(3):245-251 Original Article